Hap Trading, LLC Surface Oncology, Inc. Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.62 - $1.21 $1,364 - $2,662	-2,200 Reduced 11.17%	17,500 $0
Q3 2022 Nov 14, 2022	SELL	$1.05 - $2.1 $6,090 - $12,180	-5,800 Reduced 22.75%	19,700 $1,000
Q2 2022 Aug 12, 2022	BUY	$1.42 - $3.15 $10,934 - $24,255	7,700 Added 43.26%	25,500 $4,000
Q1 2022 May 12, 2022	SELL	$2.65 - $5.08 $41,605 - $79,756	-15,700 Reduced 46.87%	17,800 $3,000
Q4 2021 Feb 14, 2022	BUY	$4.73 - $7.9 $63,382 - $105,860	13,400 Added 66.67%	33,500 $39,000
Q3 2021 Nov 10, 2021	SELL	$5.16 - $7.98 $56,760 - $87,780	-11,000 Reduced 35.37%	20,100 $20,000
Q2 2021 Aug 11, 2021	BUY	$6.45 - $9.09 $116,745 - $164,529	18,100 Added 139.23%	31,100 $7,000
Q1 2021 May 14, 2021	BUY	$7.25 - $13.82 $94,250 - $179,660	13,000 New	13,000 $10,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.